enzh-TWfrdeitjaptrues

The 17th International Myeloma Workshop under the auspices of the International Myeloma Society (IMS) is devoted to fostering scientific and clinical exchange on the latest breakthroughs in multiple myeloma and related plasma cell disorders. The conference will take place September 12-15, 2019 at the Hynes Convention Center in Boston MA, USA. Over 3,000 participants are expected to attend the 17th IMW that will cover the latest genomic advances, insights into immune and microenvironmental dysregulation, new drug targets and agents, immunotherapeutic approaches including Car T-cell therapies, and breaking results from early and large randomized clinical trials.

The IMW 2019 will also feature a greatly expanded program of speakers and poster presenters selected from abstract submissions. Up to 40 young investigator award recipients will be selected from submitted abstracts for travel awards, and the chance to present their work and be honored at the Opening Ceremonies at the Boston Museum of Science. A black-tie event honoring IMS award recipients and workshop attendees will be held at the world-renowned Boston Museum of Fine Arts for the Closing Ceremonies. The 17th IMW will also feature a dedicated nursing symposium covering management and treatment of multiple myeloma. Nurses and allied health professionals are invited to attend and submit abstracts. Please join us for this defining conference on myeloma and the related plasma cells disorders.

For more information on this workshop, please visit http://imw2019boston.org/.

For more information or to join the International Myeloma Society, please visit https://www.myelomasociety.org/.

To watch the video highlights, please visit https://youtu.be/jsKrXND-nkU

Latest Bing Center News

Latest News in the Treatment of WM - TELECONFERENCE 3/19/2020

Latest News in the Treatment of WM - TELECONFERENCE 3/19/2020

CancerCare, in association with the IWMF, is holding a Teleconference titled –  The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia on Thursday, March 19th  from 1:10-2:30  pm Eastern Time (ET). Presenting will be Steven Treon, MD, Ph.D, Christian Buske, MD, Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW, and Carl Harrington (IWMF).

Read more..

25th Annual IWMF Educational Forum

25th Annual IWMF Educational Forum

25th Annual IWMF Educational ForumJune 5-7, 2020Renton, WA"2020 Vision: A World Without WM"

Read more..

Steven Treon, MD, PhD to serve as advisor to IWMF Board

Steven Treon, MD, PhD to serve as advisor to IWMF Board

Dr. Steven Treon, MD, PhD, (Dana-Farber Cancer Institute) has agreed to advise the IWMF Board of Trustees. Dr. Treon joins Dr. Ansell of the Mayo Clinic in providing the critical perspective of world-renowned clinicians/researchers to the IWMF Board. Dr. Treon and Dr. Ansell also will jointly co-chair the IWMF Scientific Advisory Committee.

Read more..

Florida Blood Cancer Conference 2020 (LLS)

Florida Blood Cancer Conference 2020 (LLS)

Dr. Steven Treon will be lecturing at the upcoming Blood Cancer Conference (BCC), one of many programs developed by The Leukemia & Lymphoma Society (LLS) to meet the needs of patients, survivors, families and oncology professionals, the people who deal with blood cancer every day and the people who care for them. BCC attendees receive the most current information and access to local resources to help navigate and make informed decisions about their treatment and survivorship.

Read more..

ASH 2019 - Bing Center Presentations

ASH 2019 - Bing Center Presentations

The ASH 2019 conference was held in Orlando, FL from December 7-10, 2019. Researchers from the Bing Center contributed an oral presentation (Guang Yang), and three posters (Jorge Castill, and Xia Liu).  

Read more..

IWMF Adds Three Members to Scientific Advisory Committee

IWMF Adds Three Members to Scientific Advisory Committee

The IWMF is proud to welcome three new members to its Scientific Advisory Committee (SAC) chaired by Dr. Stephen Ansell of the Mayo Clinic and Dr. Steven Treon of the Dana-Farber Cancer Institute. The new members, Dr. Zachary Hunter from Dana-Farber, Boston, USA, Dr. Christian Buske from Ulm, Germany, and Dr. Monique Minnema of The Netherlands, were invited to participate because of their expertise in specific research areas identified by the IWMF-LLS Strategic Research Roadmap for WM.

Read more..

Dr. Edward Laane - Running for WM! (Part-2)

Dr. Edward Laane - Running for WM! (Part-2)

On November3, 2019, Dr. Edward Laane ran the Osaka Yodo River Half Marathon, to raise money for Waldenstrom's research. His pure running time was 2.26.07 with his official time listed at 2.31.0. As Dr. Laane recalls, "The run was difficult. It was sunny, and a little bit hot. The first part, 6.5 miles was a little easier. My time was approximately 1h 10 min, but the second part was very difficult. But I was thinking about the patients who have gone through so much treatment and this gave me more strength to finish.

Read more..

New Approaches to treating Waldenstrom's Macroglobulinemia

New Approaches to treating Waldenstrom's Macroglobulinemia

At the 2019 Lymphoma & Myeloma Congress, Steven Treon, MD, PhD, FACP, FRCP, Harvard University, Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, Massachusetts, provided an update on the latest research in the treatment of Waldenström Macroglobulinemia.

Read more..

Dr. Edward Laane - Running for WM!

Dr. Edward Laane - Running for WM!

Dr. Edward Laane is running in the Osaka Yodo River Citizens Marathon to raise money for Waldenstrom's research!

Read more..

IMW-17 Young Investigator Awards

IMW-17 Young Investigator Awards

Congratulations to the following Bing Center researchers for their Young Investigator Awards at the 17th International Workshop on Multiple Myeloma!

Read more..